770703-33-8

Basic information

• Product Name: N-benzyl-2-(2,6-dimethoxyphenoxy)ethanamine
• CAS NO: 770703-33-8
• Molecular Formula: C₁₇H₂₁NO₃
• Molecular Weight: 287.3535
• Mol File: 770703-33-8.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 409.4°C at 760 mmHg
• Flash Point: 173.4°C
• Density: 1.088g/cm³
• Vapor Pressure: 6.5E-07mmHg at 25°C
• Refractive Index: 1.546
• CAS DataBase Reference: N-benzyl-2-(2,6-dimethoxyphenoxy)ethanamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-benzyl-2-(2,6-dimethoxyphenoxy)ethanamine(770703-33-8)
• EPA Substance Registry System: N-benzyl-2-(2,6-dimethoxyphenoxy)ethanamine(770703-33-8)

Safety Data

• Hazardous Substances Data: 770703-33-8(Hazardous Substances Data)

Upstream product

• 71084-47-4 2-(2,6-dimethoxyphenoxy)acetaldehyde 
• 100-46-9 benzylamine 

Downstream Products

• 449195-19-1 2-[benzyl[2-(2,6-dimethoxyphenoxy)ethyl]amino]-1-ethanol 

Relevant articles and documents

Structure--activity relationships among novel phenoxybenzamine-related beta-chloroethylamines.

A series of beta-chloroethylamines 5--18, structurally related to the irreversible alpha(1)-adrenoceptor antagonist phenoxybenzamine [PB, N-benzyl-N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)amine hydrochloride, 1] and the competitive antagonist WB4101 [N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-N-[2-(2,6-dimethoxyphenoxy)ethyl]amine hydrochloride, 2], were synthesized and evaluated for their activity at alpha-adrenoceptors of the epididymal and the prostatic portion of young CD rat vas deferens. All compounds displayed irreversible antagonist activity. Most of them showed similar antagonism at both alpha(1)- and alpha(2)-adrenoceptors, whereas compounds 13 and 18, lacking substituents on both the phenoxy group and the oxyamino carbon chain, displayed a moderate alpha(1)-adrenoceptor selectivity (10--35 times), which was comparable to that of PB. Compounds 14 and 15, belonging to the benzyl series and bearing, respectively, a 2-ethoxyphenoxy and a 2-i-propoxyphenoxy moiety, were the most potent alpha(1)-adrenoceptor antagonists with an affinity value similar to that of PB (pIC(50) values of 7.17 and 7.06 versus 7.27). Interestingly, several compounds were able to distinguish two alpha(1)-adrenoceptor subtypes in the epididymal tissue, as revealed by the discontinuity of their inhibition curves. A mean ratio of 24:76 for these alpha(1)-adrenoceptors was determined from compounds 8--10, 12, and 15--17. Furthermore, compounds 9, 10, 12, 16a, and 16b showed higher affinity towards the minor population of receptors, whereas compounds 8, 15, and 17 preferentially inhibited the major population of alpha(1)-adrenoceptors. In addition, selected pharmacological experiments demonstrated the complementary antagonism of the two series of compounds and their different, preferential affinity for one of the two alpha(1)-adrenoceptor subtypes. In conclusion, we found beta-chloroethylamines that demonstrate a multiplicity of alpha(1)-adrenoceptors in the epididymal portion of young CD rat vas deferens and, as a consequence, they are possible useful tools for alpha(1)-adrenoceptor characterization.